Abstract:Qing Lin, 1, 2, &ast Yafei Jing, 2, 3, &ast Cailing Yan, 2 Xinyi Chen, 2 Qiong Zhang, 2 Xinhua Lin, 2, 3 Yunlu Xu, 2, 4 Bing Chen 2, 3 1 Department of Pharmacy, Affiliated Fuzhou First Hospital of Fujian Medical University, Fujian Medical University, Fuzhou, Fujian, People's Republic of China; 2 School of Pharmacy, Fujian Medical University, Fujian, People's Republic of China; 3 Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), Fujian Medical University, Fuzhou, Fujian, People's Republic of China; 4 Center of Translational Hematology, Fujian Medical University Union Hospital, Fujian Medical University, Fuzhou, Fujian, People's Republic of China &astThese authors contributed equally to this work Correspondence: Bing Chen, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, People's Republic of China, Email ; Yunlu Xu, Center of Translational Hematology, Fujian Medical University Union Hospital, Fujian Medical University, Fuzhou, 350122, People's Republic of China, Email Background: Current immunotherapies with unexpected severe side effects and treatment resistance have not resulted in the desired outcomes for patients with melanoma, and there is a need to discover more effective medications. Cytotoxin (CTX) from Cobra Venom has been established to have favorable cytolytic activity and antitumor efficacy and is regarded as a promising novel anticancer agent. However, amphiphilic CTX with excellent anionic phosphatidylserine lipid-binding ability may also damage normal cells. Methods: We developed pH-responsive liposomes with a high CTX load (CTX@PSL) for targeted acidic-stimuli release of drugs in the tumor microenvironment. The morphology, size, zeta potential, drug-release kinetics, and preservation stability were characterized. Cell uptake, apoptosis-promoting effects, and cytotoxicity were assessed using MTT assay and flow cytometry. Finally, the tissue distribution and antitumor effects of CTX@PSL were systematically assessed using an in vivo imaging system. Results: CTX@PSL exhibited high drug entrapment efficiency, drug loading, stability, and a rapid release profile under acidic conditions. These nanoparticles, irregularly spherical in shape and small in size, can effectively accumulate at tumor sites (six times higher than free CTX) and are rapidly internalized into cancer cells (2.5-fold higher cell uptake efficiency). CTX@PSL displayed significantly stronger cytotoxicity (IC 50 0.25 μg/mL) and increased apoptosis in than the other formulations (apoptosis rate 71.78± 1.70%). CTX@PSL showed considerably better tumor inhibition efficacy than free CTX or conventional liposomes (tumor inhibition rate 79.78± 5.93%). Conclusion: Our results suggest that CTX@PSL improves tumor-site accumulation and intracellular uptake for sustained and targeted CTX release. By combining the advantages of CTX and stimuli-responsive nanotechnology, the novel CTX@PSL nanoformulation is a promising therapeutic candidate for cancer treatment. Keywords: cobra venom cytotoxin, tumor microenvironment, pH-responsive, targeted delivery, liposomes Correct diagnosis and early intervention is crucial for successful treatment of melanoma. Most malignant and highly aggressive melanoma have a high mortality rate if the opportunity for early surgical treatment is missed. 1 It is estimated that deaths due to malignant melanoma will increase by about 68% with 510,000 new cases diagnosed (approximately 50% increase) globally by the year 2040. 2 The recent development of immunotherapies and targeted therapies has brought hope to patients with malignant melanoma. However, low treatment response rates, unexpected side effects, and treatment resistance have limited their widespread use and popularity. 3,4 Therefore, there is an urgent need to develop new drugs to improve the efficacy of melanoma treatment. Cytotoxins (CTX) from cobra venom are polypeptides of 60–63 amino acid residues (relative molecular weight ~6–7 kDa, pI ≥ 10), which are key components in the venom responsible for pharmacological activity. 5,6 CTX exhibit amphiphilic properties and belong to the three-finger toxin superfamily, which can translocate to the intermembrane space to affect the integrity of lipid membranes and influence the structure and function of membrane proteins. 7–9 Previous studies have confirmed that CTX possesses a remarkable ability to induce apoptosis, necrosis, and oncolysis by activating mitochondrial and/or lysosomal cell death-associa -Abstract Truncated-

Fatty Acid Modification of the Anticancer Peptide LVTX-9 to Enhance Its Cytotoxicity against Malignant Melanoma Cells

Efficient synthesis and anticancer evaluation of spider toxin peptide LVTX-8-based analogues with enhanced stability

An Anti-Cancer Peptide LVTX-8 Inhibits the Proliferation and Migration of Lung Tumor Cells by Regulating Causal Genes’ Expression in P53-Related Pathways

A Lipid-Sensitive Spider Peptide Toxin Exhibits Selective Anti-Leukemia Efficacy through Multimodal Mechanisms

A Novel Spider Peptide Toxin Suppresses Tumor Growth Through Dual Signaling Pathways

Acid-Activated Melittin for Targeted and Safe Antitumor Therapy.

Influence of chain length on the anticancer activity of the antimicrobial peptide CAMEL with fatty acid modification

Glucose–Lipopeptide Conjugates Reveal the Role of Glucose Modification Position in Complexation and the Potential of Malignant Melanoma Therapy

Antineoplastic Effects and Mechanisms of a New RGD Chimeric Peptide from Bullfrog Skin on the Proliferation and Apoptosis of B16F10 Cells

Hybrid Melittin Cytolytic Peptide-Driven Ultrasmall Lipid Nanoparticles Block Melanoma Growth <i>in Vivo</i>

LvHemB1, a novel cationic antimicrobial peptide derived from the hemocyanin of Litopenaeus vannamei, induces cancer cell death by targeting mitochondrial voltage-dependent anion channel 1

Venom Peptides and Toxins - A Prospective Spearhead in Cancer Treatment

Hybrid melittin cytolytic Peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo.

Therapeutic Effects of Synthetic Triblock Amphiphilic Short Antimicrobial Peptides on Human Lung Adenocarcinoma

Identification of a Novel Cytolytic Peptide from Wolf Spider Lycosa Singoriensis

Design and Application of pH-Responsive Liposomes for Site-Specific Delivery of Cytotoxin from Cobra Venom

LC-AMP-F1 Derived from the Venom of the Wolf Spider Lycosa coelestis, Exhibits Antimicrobial and Antibiofilm Activities

Increased antitumor activity of tumor-specific peptide modified thymopentin.

A Litopenaeus vannamei Hemocyanin-Derived Antimicrobial Peptide (Peptide B11) Attenuates Cancer Cells’ Proliferation

Enhanced Antitumor and Anti-Metastasis Efficiency Via Combined Treatment with Cxcr4 Antagonist and Liposomal Doxorubicin

Melittin-encapsulating Peptide Hydrogels for Enhanced Delivery of Impermeable Anticancer Peptides.